|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Current assets: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Marketable securities | ||||||||||||||||
| Prepaid expenses | ||||||||||||||||
| Income tax receivable | ||||||||||||||||
| Restricted cash held on behalf of Former Parent | ||||||||||||||||
| Other current assets | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Intangible assets | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Other non-current assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||
| Current liabilities: | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Due to Former Parent | ||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||
| Forward contract liability | ||||||||||||||||
| Forward contract and derivative liability | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Non-current operating lease liability | ||||||||||||||||
| Derivative liability, non-current | ||||||||||||||||
| Notes payable | ||||||||||||||||
| Other non-current liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Shareholders' (Deficit) Equity: | ||||||||||||||||
| Preferred shares, no par value; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||
| Common shares, no par value; 200,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 151,017,531 and 132,775,113 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||
| Total shareholders' (deficit) equity | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
Loading...
